Gibbs Cancer Center & Research Institute to Participate in $93 Million National Cancer Institute Program
NCI Community Oncology Research Program (NCORP) Gets Underway
SPARTANBURG, SC, August 1, 2014 – Spartanburg Regional Healthcare System announces that Gibbs Cancer Center & Research Institute was awarded a five-year grant from the National Cancer Institute.
Gibbs Cancer Center & Research Institute received the official award notice of the research program from the National Cancer Institute Clinical Oncology Research Program (NCORP) this week.
The five-year, $93 million grant places Gibbs Cancer Center & Research Institute into an elite network of healthcare research bases and community sites that will all work together to identify and evaluate interventions that will help reduce cancer risk, increase access to clinical trials and delivery, and enhance quality of life for all patients served. Gibbs Cancer Center & Research Institute has been asked to partner with NCORP to design and conduct trials to improve cancer prevention, cancer control, screening and post-treatment management.
“The achievement of this grant is important to the mission of Gibbs Cancer Center & Research Institute ensuring our ability to bring National Cancer Institute trials to our patients,” said James D. Bearden III, M.D., Vice President of Clinical Research for Spartanburg Regional Healthcare System.
Fifty-three grants were awarded in three categories:
- Seven Research Bases function as hubs for the network, designing and conducting multi-center cancer clinical trials and cancer care delivery research and providing overall administration, data management, scientific leadership and regulatory compliance.
- 34 Community Sites accrue participants to clinical trials conducted by NCORP Research Bases, NCI National Clinical Trials Network (NCTN) treatment and imaging trials, quality of life studies and cancer care delivery research involving patients, practitioners and/or healthcare organizations.
- 12 Minority/Underserved Community Sites accrue participants in the same way as the Community Sites but have a patient population comprising at least 30% racial/ethnic minorities or rural residents.
Gibbs Cancer Center & Research Institute will be a part of the Southeast Cancer Corsortium-Upstate NCORP, which will bring in patients from South Carolina, North Carolina, Georgia, Tennessee and Virginia.
The overall goal of NCORP is to bring cancer clinical trials and cancer care delivery research to patients in their own communities. This research will contribute to improved patient outcomes and a reduction in cancer disparities. Gibbs has been a NCI research site since 1983 as a Community Clinical Oncology Program and a National Cancer Institute Community Cancer Centers Program (NCCCP) since 2007.
Additional Gibbs physicians providing leadership to this consortium are Patricia Griffin, M.D., named co-principal investigator, as well as Amy Curtis, M.D., Sharmila Mehta, M.D. and Sarah Vidito, D.O. who have been named as Young Investigators in Training.
This consortium was one of more than 100 applicants in the highly competitive NCORP selection process, including many academic institutions.
Bearden said this enables us to bring new treatments to our patients here at home.
“This will remove the necessity of some local patients needing to travel to distant research centers for treatment,” Bearden said.
For more information on NCORP, please visit http://ncorp.cancer.gov/news/ncorp-qa.pdf.
For more information on this consortium, please contact the media pager at 253-7561.